Austria · Delayed Price · Currency is EUR Novo Nordisk Statistics
Total Valuation
Novo Nordisk has a market cap or net worth of EUR 181.38 billion. The enterprise value is 195.31 billion.
| Market Cap | 181.38B |
| Enterprise Value | 195.31B |
Important Dates
The next estimated earnings date is Wednesday, February 4, 2026.
| Earnings Date | Feb 4, 2026 |
| Ex-Dividend Date | Aug 15, 2025 |
Share Statistics
| Current Share Class | 3.37B |
| Shares Outstanding | n/a |
| Shares Change (YoY) | -0.34% |
| Shares Change (QoQ) | +0.06% |
| Owned by Insiders (%) | 0.02% |
| Owned by Institutions (%) | 28.05% |
| Float | 3.19B |
Valuation Ratios
The trailing PE ratio is 13.22 and the forward PE ratio is 14.46.
| PE Ratio | 13.22 |
| Forward PE | 14.46 |
| PS Ratio | 4.38 |
| PB Ratio | 6.98 |
| P/TBV Ratio | 21.17 |
| P/FCF Ratio | 22.97 |
| P/OCF Ratio | 11.37 |
| PEG Ratio | n/a |
Enterprise Valuation
The stock's EV/EBITDA ratio is 9.61, with an EV/FCF ratio of 24.74.
| EV / Earnings | 14.24 |
| EV / Sales | 4.72 |
| EV / EBITDA | 9.61 |
| EV / EBIT | 10.64 |
| EV / FCF | 24.74 |
Financial Position
The company has a current ratio of 0.80, with a Debt / Equity ratio of 0.67.
| Current Ratio | 0.80 |
| Quick Ratio | 0.54 |
| Debt / Equity | 0.67 |
| Debt / EBITDA | 0.86 |
| Debt / FCF | 2.22 |
| Interest Coverage | 20.22 |
Financial Efficiency
Return on equity (ROE) is 60.70% and return on invested capital (ROIC) is 40.08%.
| Return on Equity (ROE) | 60.70% |
| Return on Assets (ROA) | 16.98% |
| Return on Invested Capital (ROIC) | 40.08% |
| Return on Capital Employed (ROCE) | 41.87% |
| Weighted Average Cost of Capital (WACC) | n/a |
| Revenue Per Employee | 601,544 |
| Profits Per Employee | 199,371 |
| Employee Count | 78,554 |
| Asset Turnover | 0.61 |
| Inventory Turnover | 1.23 |
Taxes
In the past 12 months, Novo Nordisk has paid 3.76 billion in taxes.
| Income Tax | 3.76B |
| Effective Tax Rate | 21.53% |
Stock Price Statistics
The stock price has decreased by -49.65% in the last 52 weeks.
| Beta (5Y) | n/a |
| 52-Week Price Change | -49.65% |
| 50-Day Moving Average | 45.56 |
| 200-Day Moving Average | 50.85 |
| Relative Strength Index (RSI) | 33.90 |
| Average Volume (20 Days) | 9,961 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, Novo Nordisk had revenue of EUR 41.38 billion and earned 13.72 billion in profits. Earnings per share was 3.08.
| Revenue | 41.38B |
| Gross Profit | 33.92B |
| Operating Income | 18.35B |
| Pretax Income | 17.48B |
| Net Income | 13.72B |
| EBITDA | 20.31B |
| EBIT | 18.35B |
| Earnings Per Share (EPS) | 3.08 |
Balance Sheet
The company has 3.61 billion in cash and 17.53 billion in debt, with a net cash position of -13.92 billion.
| Cash & Cash Equivalents | 3.61B |
| Total Debt | 17.53B |
| Net Cash | -13.92B |
| Net Cash Per Share | n/a |
| Equity (Book Value) | 25.98B |
| Book Value Per Share | 5.85 |
| Working Capital | -5.79B |
Cash Flow
In the last 12 months, operating cash flow was 15.95 billion and capital expenditures -8.05 billion, giving a free cash flow of 7.89 billion.
| Operating Cash Flow | 15.95B |
| Capital Expenditures | -8.05B |
| Free Cash Flow | 7.89B |
| FCF Per Share | n/a |
Margins
Gross margin is 81.97%, with operating and profit margins of 44.34% and 33.14%.
| Gross Margin | 81.97% |
| Operating Margin | 44.34% |
| Pretax Margin | 42.24% |
| Profit Margin | 33.14% |
| EBITDA Margin | 49.08% |
| EBIT Margin | 44.34% |
| FCF Margin | 19.08% |
Dividends & Yields
This stock pays an annual dividend of 1.56, which amounts to a dividend yield of 3.84%.
| Dividend Per Share | 1.56 |
| Dividend Yield | 3.84% |
| Dividend Growth (YoY) | 17.65% |
| Years of Dividend Growth | 8 |
| Payout Ratio | 50.53% |
| Buyback Yield | 0.34% |
| Shareholder Yield | 4.18% |
| Earnings Yield | 7.56% |
| FCF Yield | 4.35% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | |
| Lynch Upside | |
| Graham Number | |
| Graham Upside |
Stock Splits
The last stock split was on September 13, 2023. It was a forward split with a ratio of 2.
| Last Split Date | Sep 13, 2023 |
| Split Type | Forward |
| Split Ratio | 2 |
Scores
Novo Nordisk has an Altman Z-Score of 5.12 and a Piotroski F-Score of 5.
| Altman Z-Score | 5.12 |
| Piotroski F-Score | 5 |